Activation of the cyclin E/CDK2 complex promotes uncontrolled cell proliferation and malignant transformation, highlighting the cyclin E/CDK2 complex as a promising target for therapeutic intervention in cancer treatment. This evidence concerns the gene CDK2 and cancer.